Showing results (271-280 of 499) with videos related to

Sort By:
Pageof 50
Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology|December 14, 2020
European experience with a first totally leadless cardiac resynchronization therapy pacemaker systemAdrien Carabelli, Mariem Jabeur, Peggy Jacon, et al.
Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology|May 16, 2015
First clinical evaluation of an atrial haemodynamic sensor lead for automatic optimization of cardiac resynchronization therapyDavid Duncker, Peter Paul Delnoy, Herbert Nägele, et al.
Archives of Cardiovascular Diseases|June 5, 2021
Impact of COVID-19 on the incidence of cardiac arrhythmias in implantable cardioverter defibrillator recipients followed by remote monitoringVincent Galand, Elliot Hwang, Estelle Gandjbakhch, et al.
Heart (British Cardiac Society)|June 25, 2014
Iron deficiency: an emerging therapeutic target in heart failureAlain Cohen-Solal, Christophe Leclercq, Gilbert Deray, et al.
Journal of Cardiovascular Electrophysiology|July 29, 2014
Positive response to cardiac resynchronization therapy reduces arrhythmic events after elective generator change in patients with primary prevention CRT-DFrederic A Sebag, Nicolas Lellouche, Zhong Chen, et al.
International Journal of Cardiology|March 27, 2018
Benefits of left ventricular endocardial pacing comparing failed implants and prior non-responders to conventional cardiac resynchronization therapy: A subanalysis from the ALSYNC studyMauro Biffi, Pascal Defaye, Pierre Jaïs, et al.
Archives of Cardiovascular Diseases|November 9, 2024
Epidemiology of major heart rhythm and conduction disordersAmélie Gabet, Grégory Lailler, Laurent Fauchier, et al.
European Heart Journal|February 15, 2007
Early and sustained effects of cardiac resynchronization therapy on N-terminal pro-B-type natriuretic peptide in patients with moderate to severe heart failure and cardiac dyssynchronyFriedrich M Fruhwald, Astrid Fahrleitner-Pammer, Rudolf Berger, et al.
European Journal of Heart Failure|July 22, 2014
Association between cardiovascular vs. non-cardiovascular co-morbidities and outcomes in heart failure with preserved ejection fractionLars H Lund, Erwan Donal, Emmanuel Oger, et al.
Archives of Cardiovascular Diseases|April 27, 2020
Subcutaneous implantable cardioverter defibrillator indication in prevention of sudden cardiac death in difficult clinical situations: A French expert position paperVincent Probst, Serge Boveda, Nicolas Sadoul, et al.
Pageof 50